These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19098487)

  • 21. Neutralizing antibodies decrease the envelope fluidity of HIV-1.
    Harada S; Monde K; Tanaka Y; Kimura T; Maeda Y; Yusa K
    Virology; 2008 Jan; 370(1):142-50. PubMed ID: 17900650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combining human antisera to human leukocyte antigens, HIVgp120 and 70 kDa heat shock protein results in broadly neutralizing activity to HIV-1.
    Babaahmady K; Bergmeier LA; Lehner T
    AIDS; 2008 Jul; 22(11):1267-76. PubMed ID: 18580605
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Elimination of HIV-1 infection by treatment with a doxorubicin-conjugated anti-envelope antibody.
    Johansson S; Goldenberg DM; Griffiths GL; Wahren B; Hinkula J
    AIDS; 2006 Oct; 20(15):1911-5. PubMed ID: 16988511
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Saliva can mediate HIV-1-specific antibody-dependent cell-mediated cytotoxicity.
    Kim JS; Nag P; Landay AL; Alves M; Cohn MH; Bremer JW; Baum LL
    FEMS Immunol Med Microbiol; 2006 Nov; 48(2):267-73. PubMed ID: 16978244
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neutralizing monoclonal antibodies to human immunodeficiency virus type 1 do not inhibit viral transcytosis through mucosal epithelial cells.
    Chomont N; Hocini H; Gody JC; Bouhlal H; Becquart P; Krief-Bouillet C; Kazatchkine M; Bélec L
    Virology; 2008 Jan; 370(2):246-54. PubMed ID: 17920650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 envelope pseudotyped viral vectors and infectious molecular clones expressing the same envelope glycoprotein have a similar neutralization phenotype, but culture in peripheral blood mononuclear cells is associated with decreased neutralization sensitivity.
    Louder MK; Sambor A; Chertova E; Hunte T; Barrett S; Ojong F; Sanders-Buell E; Zolla-Pazner S; McCutchan FE; Roser JD; Gabuzda D; Lifson JD; Mascola JR
    Virology; 2005 Sep; 339(2):226-38. PubMed ID: 16005039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predominant mode of human immunodeficiency virus transfer between T cells is mediated by sustained Env-dependent neutralization-resistant virological synapses.
    Chen P; Hübner W; Spinelli MA; Chen BK
    J Virol; 2007 Nov; 81(22):12582-95. PubMed ID: 17728240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Changing sensitivity to broadly neutralizing antibodies b12, 2G12, 2F5, and 4E10 of primary subtype B human immunodeficiency virus type 1 variants in the natural course of infection.
    Bunnik EM; van Gils MJ; Lobbrecht MS; Pisas L; van Nuenen AC; Schuitemaker H
    Virology; 2009 Aug; 390(2):348-55. PubMed ID: 19539340
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Human genital epithelial cells capture cell-free human immunodeficiency virus type 1 and transmit the virus to CD4+ Cells: implications for mechanisms of sexual transmission.
    Wu Z; Chen Z; Phillips DM
    J Infect Dis; 2003 Nov; 188(10):1473-82. PubMed ID: 14624372
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peptide P5 (residues 628-683), comprising the entire membrane proximal region of HIV-1 gp41 and its calcium-binding site, is a potent inhibitor of HIV-1 infection.
    Yu H; Tudor D; Alfsen A; Labrosse B; Clavel F; Bomsel M
    Retrovirology; 2008 Oct; 5():93. PubMed ID: 18925934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-multiplicity HIV-1 infection and neutralizing antibody evasion mediated by the macrophage-T cell virological synapse.
    Duncan CJ; Williams JP; Schiffner T; Gärtner K; Ochsenbauer C; Kappes J; Russell RA; Frater J; Sattentau QJ
    J Virol; 2014 Feb; 88(4):2025-34. PubMed ID: 24307588
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carbohydrate-binding agents (CBAs) inhibit HIV-1 infection in human primary monocyte-derived macrophages (MDMs) and efficiently prevent MDM-directed viral capture and subsequent transmission to CD4+ T lymphocytes.
    Pollicita M; Schols D; Aquaro S; Peumans WJ; Van Damme EJ; Perno CF; Balzarini J
    Virology; 2008 Jan; 370(2):382-91. PubMed ID: 17928023
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characterization of a trimeric MPER containing HIV-1 gp41 antigen.
    Hinz A; Schoehn G; Quendler H; Hulsik DL; Stiegler G; Katinger H; Seaman MS; Montefiori D; Weissenhorn W
    Virology; 2009 Aug; 390(2):221-7. PubMed ID: 19539967
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transmembrane domain membrane proximal external region but not surface unit-directed broadly neutralizing HIV-1 antibodies can restrict dendritic cell-mediated HIV-1 trans-infection.
    Sagar M; Akiyama H; Etemad B; Ramirez N; Freitas I; Gummuluru S
    J Infect Dis; 2012 Apr; 205(8):1248-57. PubMed ID: 22396600
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Galactosyl ceramide expressed on dendritic cells can mediate HIV-1 transfer from monocyte derived dendritic cells to autologous T cells.
    Magérus-Chatinet A; Yu H; Garcia S; Ducloux E; Terris B; Bomsel M
    Virology; 2007 May; 362(1):67-74. PubMed ID: 17234232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detection of very early antibody to native HIV antigens by HIV neutralization and live-cell immunofluorescence assays.
    Pan J; Chen J; Lee H; Sahu GK; Poast JS; Tyring S; Cloyd M; Baron S
    Antiviral Res; 2006 Jun; 70(2):21-7. PubMed ID: 16513186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. C-type lectin Mermaid inhibits dendritic cell mediated HIV-1 transmission to CD4+ T cells.
    Nabatov AA; de Jong MA; de Witte L; Bulgheresi S; Geijtenbeek TB
    Virology; 2008 Sep; 378(2):323-8. PubMed ID: 18597806
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies.
    Huarte N; Lorizate M; Kunert R; Nieva JL
    FEBS Lett; 2008 Nov; 582(27):3798-804. PubMed ID: 18930052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mother to child transmission of HIV-1 in a Thai population: role of virus characteristics and maternal humoral immune response.
    Kittinunvorakoon C; Morris MK; Neeyapun K; Jetsawang B; Buehring GC; Hanson CV
    J Med Virol; 2009 May; 81(5):768-78. PubMed ID: 19319941
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.